https://biotechmorning.com/news/hiv-drug-came-back-from-dead-idvynso Biotech Morning en 2026-05-01T14:13:04.133Z The HIV Drug That Came Back From the Dead https://biotechmorning.com/news/bms-terminates-zymeworks-bispecific-collaboration Biotech Morning en 2026-05-01T14:12:23.241Z BMS Just Ghosted a Decade-Old Partnership. Zymeworks Felt That. https://biotechmorning.com/news/astrazeneca-camizestrant-fda-panel-rejection Biotech Morning en 2026-05-01T14:11:43.744Z AstraZeneca Bet Big on Catching Cancer Before It Spreads. The FDA Wasn't Buying It. https://biotechmorning.com/news/jnj-cancels-car-t-program Biotech Morning en 2026-05-01T14:10:56.678Z J&J Just Torched $5 Billion in CAR-T Progress. Nobody Saw It Coming. https://biotechmorning.com/news/indivior-phase-2-failure-rd-layoffs Biotech Morning en 2026-05-01T14:10:09.469Z One Failed Trial Just Gutted Indivior's Entire R&D Operation https://biotechmorning.com/news/leo-pharma-replay-gene-therapy-skin Biotech Morning en 2026-05-01T14:09:32.430Z A $50M Bet That Herpes Could Fix Your Skin https://biotechmorning.com/news/glp1-revolution-ditched-the-needle Biotech Morning en 2026-05-01T14:08:51.340Z The GLP-1 Revolution Just Ditched the Needle https://biotechmorning.com/news/amgen-kills-two-programs-phase-2-failures Biotech Morning en 2026-05-01T14:08:11.498Z Amgen Just Killed Two Programs in One Week. Should Investors Worry? https://biotechmorning.com/news/astrazeneca-pinetree-egfr-degrader-deal Biotech Morning en 2026-04-30T14:11:42.543Z AstraZeneca's $25M Bet on a Drug That Destroys What Others Can't Block https://biotechmorning.com/news/astrazeneca-camizestrant-truqap-odac-meeting-fda-concerns Biotech Morning en 2026-04-30T14:11:02.608Z AstraZeneca's Two Biggest Cancer Bets Just Hit the Same Wall https://biotechmorning.com/news/teva-700m-emalex-tourette-syndrome-bet Biotech Morning en 2026-04-30T14:10:17.561Z Teva's $700M Bet on a Drug That Hasn't Been Updated in 50 Years https://biotechmorning.com/news/avalyn-pharma-300m-ipo-inhaled-pulmonary-fibrosis Biotech Morning en 2026-04-30T14:09:39.194Z The $300M Bet That Breathing Easier Starts in the Lungs https://biotechmorning.com/news/2-billion-bet-preclinical-trispecific-antibody Biotech Morning en 2026-04-30T14:08:55.107Z A $2 Billion Bet on a Drug That Hasn't Touched a Human Yet https://biotechmorning.com/news/fda-clinical-hold-newron-schizophrenia-trial Biotech Morning en 2026-04-30T14:08:12.617Z A Patient Died in a Schizophrenia Trial. Now the FDA Wants Answers. https://biotechmorning.com/news/gsk-alector-alzheimers-second-failure Biotech Morning en 2026-04-30T14:07:32.867Z GSK Bet $700M on a Brain Theory. It Just Lost Twice. https://biotechmorning.com/news/chiesi-kalvista-oral-hae-acquisition Biotech Morning en 2026-04-30T14:06:50.916Z The $1.9B Bet That Needles Are Going Extinct in One Corner of Medicine